Peripheral T-Cell Lymphoma, Not Otherwise Specified – a case report and short literature review
Abstract
##plugins.themes.bootstrap3.article.details##
Peripheral T-cell lymphoma, PTCL-NOS, lymphadenopathy, DRESS syndrome
2. Amador C, Greiner TC, Heavican TB, et al. Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry. Blood. 2019; 134(24):2159-2170. PMID: 31562134; PMCID: PMC6908831, doi: 10.1182/blood.2019000779.
3. Broccoli A, Zinzani PL. Peripheral T-cell lymphoma, not otherwise specified. Blood. 2017; 129(9):1103-1112. PMID: 28115372, doi: 10.1182/blood-2016-08-692566.
4. Abouyabis AN, Shenoy PJ, Lechowicz MJ, Flowers CR. Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States. Leuk Lymphoma. 2008; 49(11):2099-2107. doi: 10.1080/10428190802455867.
5. Park HS, McIntosh L, Braschi-Amirfarzan M, Shinagare AB, Krajewski KM. T-Cell Non-Hodgkin Lymphomas: Spectrum of Disease and the Role of Imaging in the Management of Common Subtypes. Korean J Radiol. 2017; 18(1):71-83. PMID: 28096719; PMCID: PMC5240486, doi: 10.3348/kjr.2017.18.1.71.
6. Zinzani PL, Broccoli A. T-cell lymphoproliferative disorders. In: Hoffbrand V, Higgs DR, Keeling DM, et al, eds. Postgraduate hematology, 7th ed. Hoboken, NJ: Wiley Blackwell; 2016:524–536.
7. Choudhary S, McLeod M, Torchia D, Romanelli P. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome. J Clin Aesthet Dermatol. 2013; 6(6):31-37. PMID: 23882307; PMCID: PMC3718748.
8. Fox CP, Ahearne MJ, Pettengell R, et al. Guidelines for the management of mature T- and natural killer-cell lymphomas (excluding cutaneous T-cell lymphoma): a British Society for Haematology Guideline. Br J Haematol. 2022; 196(3):507-522. PMID: 34811725, doi: 10.1111/bjh.17951.
9. Gaulard P, de Leval L. Pathology of peripheral T-cell lymphomas: where do we stand? Semin Hematol. 2014; 51(1):5-16. PMID: 24468311, doi: 10.1053/j.seminhematol.2013.11.003.
10. dAmore F, Gaulard P, Trümper L, et al. Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015; 26 Suppl 5:v108-115. PMID: 26314772,
doi: 10.1093/annonc/mdv201.
11. Moon SH, Cho SK, Kim WS, et al. The role of 18F-FDG PET/CT for initial staging of nasal type natural killer/T-cell lymphoma: a comparison with conventional staging methods. J Nucl Med. 2013; 54(7):1039-1044. PMID: 23658217, doi: 10.2967/jnumed.112.113399.
12. Zhang XM, Li YX, Wang WH, et al. Survival advantage with the addition of radiation therapy to chemotherapy in early-stage peripheral T-cell lymphoma, not otherwise specified. Int J Radiat Oncol Biol Phys. 2013; 85(4):1051-1056. PMID: 23021436, doi: 10.1016/j.ijrobp.2012.08.015.
13. Siegert W, Agthe A, Griesser H, et al. Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group. Ann Intern Med. 1992; 117(5):364-370. PMID: 1380221, doi: 10.7326/0003-4819-117-5-364.
14. Horwitz S, OConnor OA, Pro B, et al. Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial. Lancet. 2019; 393(10168):229-240. doi: 10.1016/S0140-6736(18)32984-2. Erratum in: Lancet. 2019; 393(10168):228. PMID: 30522922; PMCID:
PMC6436818.
15. Bachy E, Camus V, Thieblemont C, et al. Romidepsin Plus CHOP versus CHOP in patients with previously untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA). J Clin Oncol. 2022; 40(3):242-251. PMID: 34843406, doi: 10.1200/JCO.21.01815.
16. Gutiérrez-García G, García-Herrera A, Cardesa T, et al. Comparison of four prognostic scores in peripheral T-cell lymphoma. Ann Oncol. 2011; 22(2):397-404. PMID: 20631009, doi: 10.1093/annonc/mdq359.
17. Mak V, Hamm J, Chhanabhai M, et al. Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors. J Clin Oncol. 2013; 31(16):1970-1976. PMID: 23610113, doi: 10.1200/JCO.2012.44.7524.
Archive of Clinical Cases is protected by copyright and may be used in accordance with copyright and other applicable laws. Content available at www.clinicalcases.eu and our digital applications is intended for personal noncommercial use.
Authors who submit a manuscript for publication in Archive of Clinical Cases agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) only after the final version of the manuscript was accepted and published, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). d. It is compulsory that before submission authors ensure that their work was not published in any other medical journals or pending acceptance for publication and that "Archives of Clinical Cases" is the only beneficiary at that moment if their work/case will be accepted by us.
Guidelines for linking to www.clinicalcases.eu a. The main purpose of the site linking to the Archive of Clinical Casess site should be educational. b. Links should be made to the Archive of Clinical Casess home page (www.clinicalcases.eu) or to the articles abstract. c. It is forbidden to use the Archive of Clinical Casess cover by outside organizations unless permission has been granted in advance, notifying our Secretary. d. Material owned by the Archive of Clinical Cases (including the name, logo, cover, and text) may not be used in any manner that may induce the idea or suggest that the Archive of Clinical Cases is in some way recommending a specific company, product or service. e. You must not use or allow others to access or use, all or any part of our Site or the contents and/or applications on it for commercial purposes without our permission. To seek permission to do anything prohibited by or not contained in these TERMS, or which requires our prior consent or agreement, you can contact us.